Autophagosomal Sequestration of Mitochondria as an Indicator of Antiandrogen TherapyResistance of Prostate Cancer (PCa)
Abstract
Purpose: We are investigating if sequestration of metabolically dysfunctional mitochondria by the autophagosomes (mitophagy) imparts anti-androgen resistance and if this phenomenon can be applied in circulating tumor cells in patient blood samples as a biomarker for development of drug resistance. Method: Effects of the anti-androgen enzalutamide on the autophagy and mitophagy of androgen-dependent LNCaP and independent C4-2 and CWR22v1 cells are studied first. Autophagy is monitored by fluorescence of cells with anti-LC3B antibody. Cellular fluorescence due to Mitosox dye oxidation is used to identify mitochondria producing high superoxide (O2-).
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2018
- Accession Number
- AD1095565
Entities
People
- George Wilding
Organizations
- University of Texas at Austin